Pfizer Inc.
PFEEquityAI Summary
Updated 8h ago
Pfizer Inc
Pfizer Inc. (PFE) is in a mixed position. Some indicators are above average, others below, but nothing is at an extreme that demands attention. For reference: Flow Score 56/100, Trend & Momentum Score 48/100.
Market Positioning
What's Happening
Pfizer locks in 2026 guidance and cost-reset targets
On 2026-05-29, Pfizer reaffirmed full-year 2026 revenue guidance of $59.5 billion to $62.5 billion and EPS guidance of $2.80 to $3.00, while also calling for operational revenue growth of about 4% at the midpoint excluding COVID-19 and LOE products. The detail that matters is the margin bridge — Pfizer is pairing top-line stabilization with $23.0 billion to $25.0 billion in combined adjusted SI&A and R&D spending, which signals the company is still leaning hard on its cost realignment program to defend earnings power.
The Bigger Picture
Macro context will be updated shortly
Upcoming Catalysts
Updated 48d agoPfizer often uses the weeks before earnings to reinforce guidance and shape expectations through investor communications and conference appearances. Any update that clarifies the pace of operational revenue growth or expense control could matter more than the headline itself. [6][4]
Pfizer is widely expected to report around this date based on market calendars. Investors will focus on whether the company keeps validating its 2026 revenue and EPS guide and whether cost realignment is continuing to support margins. [3][1]
Investors will watch for any management commentary that confirms the full-year revenue range of $59.5 billion to $62.5 billion and adjusted EPS of $2.80 to $3.00. The key issue is whether Pfizer can hold that frame without further reliance on one-off support from legacy product trends. [1]
Technical Analysis
Market Positioning
Where does this asset sit across four dimensions? Extension (how stretched price is vs its own history), Momentum (RSI, MACD, rate of change), Flow (volume and money flow), and Volatility (how quiet or active). Each bar shows a 0–100 percentile compared to the last year of data. Key levels show the nearest demand and supply zones from our confluence analysis.
Key Levels
Looking at the full picture for Pfizer Inc. (PFE): extension is slightly below average (39th percentile), momentum is above average (74th percentile), flow is above average (71st percentile), volatility is below average (29th percentile).
Where is money flowing?
Trend
Is momentum building or fading?
What is the relative strength?
How extended is this move?
Where are the key levels?
What risk am I taking?
Conclusion
Pfizer Inc. (PFE) is in a mixed position. Some indicators are above average, others below, but nothing is at an extreme level that defines the current setup strongly in either direction. There is not a strong signal here in either direction. This is an asset to watch rather than act on right now. These readings update daily. Flipside shows what is happening now, grounded in the data — not what will happen next.
Your portfolio. Your context. Smarter decisions.
Connect your holdings and let the Flipside Agent analyze market changes through the lens of your portfolio.
Personalized insights based on your actual holdings
Major market movements delivered to your inbox
Track the assets that matter most to you
No credit card required